Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SYHX2008 in Acromegaly
NCT07814651Phase 2Completed
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology
- Start
- Apr 2024
- Primary completion
- Apr 2026
- Countries
- 1
01
Overview
Phase 2, randomised trial of SYHX2008 in acromegaly (2 arms), sponsored by CSPC ZhongQi Pharmaceutical Technology. Primary endpoint: Proportion of patients with an IGF-1 index <= 1.0 at 12 weeks. Started Apr 2024; status: completed.
02
Drugs
SYHX2008
03
Conditions
acromegaly
Beyond the preview
Go deeper on NCT07814651.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07814651.